J
Janaki Deepak
Researcher at University of Maryland, Baltimore
Publications - 31
Citations - 1421
Janaki Deepak is an academic researcher from University of Maryland, Baltimore. The author has contributed to research in topics: Lung cancer & Medicine. The author has an hindex of 7, co-authored 20 publications receiving 1268 citations.
Papers
More filters
Journal ArticleDOI
Aldehyde dehydrogenase 1 is a tumor stem cell-associated marker in lung cancer.
Feng Jiang,Qi Qiu,Abha Khanna,Nevins W. Todd,Janaki Deepak,Lingxiao Xing,Huijun Wang,Zhenqiu Liu,Yun Su,Sanford A. Stass,Ruth L. Katz +10 more
TL;DR: Immunohistochemical analysis of 303 clinical specimens from three independent cohorts of lung cancer patients and controls show that expression of ALDH1 is positively correlated with the stage and grade of lung tumors and related to a poor prognosis for the patients with early-stage lung cancer.
Journal ArticleDOI
Altered miRNA expression in sputum for diagnosis of non-small cell lung cancer.
Ying Xie,Nevins W. Todd,Zhenqiu Liu,Min Zhan,Hong-Bin Fang,Hong Peng,Mohammed Alattar,Janaki Deepak,Sanford A. Stass,Feng Jiang +9 more
TL;DR: The measurement of altered miRNA expression in sputum could be a useful noninvasive approach for the diagnosis of lung cancer.
Journal ArticleDOI
Downregulation of miR-486-5p contributes to tumor progression and metastasis by targeting protumorigenic ARHGAP5 in lung cancer
J. Wang,X Tian,R Han,Xin-hua Zhang,Xiaolu Wang,H Shen,L Xue,Y Liu,Xiaojuan Yan,Jun Shen,Kaiissar Mannoor,Janaki Deepak,James M. Donahue,Sanford A. Stass,Lingxiao Xing,Feng Jiang +15 more
TL;DR: In this article, the role of miR-486-5p in the progression and metastasis of non-small-cell lung cancer (NSCLC) was investigated.
Journal ArticleDOI
Centrilobular emphysema combined with pulmonary fibrosis results in improved survival
Nevins W. Todd,Nevins W. Todd,Jean Jeudy,Sachin Lavania,Teri J. Franks,Teri J. Franks,Jeffrey R. Galvin,Jeffrey R. Galvin,Janaki Deepak,E. Britt,Sergei P. Atamas,Sergei P. Atamas +11 more
TL;DR: Patients with pulmonary fibrosis combined with advanced centrilobular or mixed emphysema have an improved survival compared with patients withmonary fibrosis without emphySEma, with trivial emphyema or with advanced paraseptal emphySema.
Journal ArticleDOI
Microbiota Biomarkers for Lung Cancer
TL;DR: In this paper, the potential use of microbiome as biomarkers for the early detection of non-small cell lung cancer (NSCLC) was evaluated using droplet digital PCR to analyze 25 NSCLC-associated bacterial genera in 31 lung tumor and the paired non-cancerous lung tissues and sputum of 17 nonsmokers and ten cancer-free smokers.